Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by University Hospital, Basel, Switzerland
Sponsor:
Collaborators:
University Hospital, Zürich
University Hospital, Geneva
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT01779882
First received: January 28, 2013
Last updated: August 2, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)